Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Motor Activity 1Disease 1Depression 1Body Weight Changes 1Body Weight 1Anxiety Disorders 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Professional Autonomy × Breast × Clear all
NCT02030353 2016-01-20

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
35 enrolled
Breast

Body Weight, Body Weight Changes, Breast Neoplasms

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

University of Western Ontario, Canada

Phase 2 Completed
7 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡